These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10231084)

  • 1. Implicit valuation of a blood-exclusion decision.
    Kaplan EH
    Med Decis Making; 1999; 19(2):207-13. PubMed ID: 10231084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Israel's ban on use of Ethiopians' blood: how many infectious donations were prevented?
    Kaplan EH
    Lancet; 1998 Apr; 351(9109):1127-8. PubMed ID: 9660600
    [No Abstract]   [Full Text] [Related]  

  • 3. Israel's ban on Ethiopians' blood.
    Fischer A
    Lancet; 1998 Jun; 351(9119):1894. PubMed ID: 9652709
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of HIV infection among Israel's Ethiopian immigrants.
    Fishman RH
    Lancet; 1996 Feb; 347(8998):389. PubMed ID: 8598710
    [No Abstract]   [Full Text] [Related]  

  • 5. Health based exclusion grounds in United States immigration policy: homosexuals, HIV infection and the medical examination of aliens.
    Shoop LG
    J Contemp Health Law Policy; 1993; 9():521-44. PubMed ID: 10126948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Babies born to Ethiopian immigrant mothers in Israel have been needlessly infected with HIV.
    Siegel-Itzkovich J
    BMJ; 2008 Oct; 337():a2308. PubMed ID: 18971228
    [No Abstract]   [Full Text] [Related]  

  • 7. A model-based evaluation of a cultural mediator outreach program for HIV+ Ethiopian immigrants in Israel.
    Kaplan EH; Soskolne V; Adler B; Leventhal A; Shtarkshall RA
    Eval Rev; 2002 Aug; 26(4):382-94. PubMed ID: 12174537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Israelis destroy Ethiopian blood donations.
    Siegel-Itzkovich J
    BMJ; 1996 Feb; 312(7027):331. PubMed ID: 8611824
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunity costs and uncertainty in the economic evaluation of health care interventions.
    Sendi P; Gafni A; Birch S
    Health Econ; 2002 Jan; 11(1):23-31. PubMed ID: 11788979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe.
    McFarland W; Kahn JG; Katzenstein DA; Mvere D; Shamu R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):183-92. PubMed ID: 7749797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "One people, one blood": public health, political violence, and HIV in an Ethiopian-Israeli setting.
    Seeman D
    Cult Med Psychiatry; 1999 Jun; 23(2):159-95. PubMed ID: 10451801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
    van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
    Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
    Zegeye EA; Mbonigaba J; Kaye SB; Wilkinson T
    Appl Health Econ Health Policy; 2017 Feb; 15(1):33-43. PubMed ID: 27637919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of HIV testing: accounting for differential participation rates.
    Paltiel AD; Kaplan EH
    Med Decis Making; 1997; 17(4):490-5. PubMed ID: 9343808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
    Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
    JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration and HIV prevention programmes: linking structural factors, culture, and individual behaviour--an Israeli experience.
    Soskolne V; Shtarkshall RA
    Soc Sci Med; 2002 Oct; 55(8):1297-1307. PubMed ID: 12231010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.